BeOne Medicines: Wang sells 31,028 depositary shares
The scientific advisory board chair's sales were made under a Rule 10b5-1 plan adopted June 9, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Xiaodong Wang, BeOne Medicines Ltd.’s Chair of the Scientific Advisory Board, exercised share options covering 403,364 Ordinary Shares at $2.84 per Ordinary Share on September 28, 2026, acquiring 31,028 American Depositary Shares (ADS); each ADS represents 13 Ordinary Shares. He reported sales of 31,028 ADS under a Rule 10b5-1 plan adopted June 9, 2026. He also reported direct holdings of 4,588,113 Ordinary Shares and options covering 806,715 Ordinary Shares after the transactions.
Insider Trade Summary 10b5-1
Exercise and sale activity reported; no spread calculated
Exercise and Sale
16 txns
Insider
Wang Xiaodong
Role
Director
Sold
31,028 shs ($11.32M)
Approx. gross sale proceeds
$11.32M
Approx. exercise cost
$1.15M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Share Option (Right to Buy) F15, F16 | 403,364 | $0.00 | $0.00 |
| Exercise | American Depositary Shares F4 | 31,028 | $36.90 | $1.14M |
| Sale | American Depositary Shares F4, F5, F6 | 160 | $356.9662 | $57K |
| Sale | American Depositary Shares F4, F5, F7 | 120 | $358.7067 | $43K |
| Sale | American Depositary Shares F4, F5 | 40 | $359.16 | $14K |
| Sale | American Depositary Shares F4, F5, F8 | 2,241 | $361.0529 | $809K |
| Sale | American Depositary Shares F4, F5, F9 | 4,239 | $362.1675 | $1.54M |
| Sale | American Depositary Shares F4, F5, F10 | 3,499 | $363.0995 | $1.27M |
| Sale | American Depositary Shares F4, F5, F11 | 3,419 | $364.0675 | $1.24M |
| Sale | American Depositary Shares F4, F5, F12 | 2,047 | $365.8479 | $749K |
| Sale | American Depositary Shares F4, F5, F13 | 14,525 | $366.5783 | $5.32M |
| Sale | American Depositary Shares F4, F5, F14 | 738 | $367.2252 | $271K |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares F1 | -- | -- | -- |
| holding | Ordinary Shares F2 | -- | -- | -- |
| holding | Ordinary Shares F3 | -- | -- | -- |
Holdings After Transaction:
Share Option (Right to Buy) — 806,715 contracts (Direct);
American Depositary Shares — 0 shares (Direct);
Ordinary Shares — 4,588,113 shares (Direct);
Ordinary Shares — 4,978,213 shares (Indirect, See Footnote)
Footnotes (16)
- F1. These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership.
- F2. These securities are held by Wang Investment LLC, of which 99% of the limited liability company interests are owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership.
- F3. These securities are held by the spouse of the Reporting Person.
- F4. Each American Depositary Share represents 13 Ordinary Shares.
- F5. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2026.
- F6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $356.94 to $357.07, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $358.11 to $359.01, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $360.65 to $361.64, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $361.66 to $362.65, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $362.67 to $363.59, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F11. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $363.67 to $364.62, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $365.13 to $366.12, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F13. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $366.13 to $367.12, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F14. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $367.13 to $367.25, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F15. The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.
- F16. These securities vest over a four-year period as follows: 25% on July 13, 2017, and the remaining in 36 successive equal monthly installments, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon certain termination events.
Key Figures
Shares underlying options exercised: 403,364 Ordinary Shares
Exercise price: $2.84 per Ordinary Share
ADS acquired: 31,028 ADS
+4 more
7 metrics
Shares underlying options exercised
403,364 Ordinary Shares
September 28, 2026
Exercise price
$2.84 per Ordinary Share
Share options exercised September 28, 2026
ADS acquired
31,028 ADS
September 28, 2026
ADS sold
31,028 ADS
September 28, 2026; under a Rule 10b5-1 trading plan
ADS ratio
13 Ordinary Shares per ADS
Ratio stated for American Depositary Shares
Direct Ordinary Shares held
4,588,113 Ordinary Shares
Reported after the September 28, 2026 transactions
Options remaining
806,715 Ordinary Shares
Reported following the option exercise
Key Terms
Rule 10b5-1 trading plan, American Depositary Share, weighted average price
3 terms
Rule 10b5-1 trading plan regulatory
"sale was effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"price reported in Column 4 is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many ONC ADS did Xiaodong Wang sell?
Xiaodong Wang reported sales of 31,028 American Depositary Shares on September 28, 2026, under a Rule 10b5-1 plan adopted June 9, 2026.
What options did ONC scientific advisory chair Xiaodong Wang exercise?
He exercised share options covering 403,364 Ordinary Shares at $2.84 per Ordinary Share and acquired 31,028 ADS; each ADS represents 13 Ordinary Shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
